XML 61 R50.htm IDEA: XBRL DOCUMENT
v3.22.2

License Agreements - InnoCare (Details) - InnoCare - tafasitamab - USD ($) $ in Millions | 1 Months Ended
--- | ---
Sep. 30, 2021 | Aug. 31, 2021
Upfront payment received under license agreement | $ 35.0 |
Maximum |  |
Upfront and immediate milestone payment to be received under license agreement |  | $ 82.5

X
- Definition Represents the upfront and immediate milestone payment received under the license agreement. + References No definition available. + Details
Name: | incy_LicenseAgreementUpfrontPaymentAndImmediateMilestonePaymentToBeReceived
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the upfront payment received under the license agreement. + References No definition available. + Details
Name: | incy_LicenseAgreementUpfrontPaymentReceived
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=incy_InnocarePharmaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=incy_TafasitamabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |